Dacinostat (LAQ824) is known to inhibit HDAC1 but is also reported as a potent HDAC inhibitor and was shown to be effective against myeloid leukemia cells in vitro and in vivo [34]. This evidence concerns the gene HDAC9 and myeloid leukemia.